FRISSORA MARK P 4
4 · BIOADAPTIVES, INC. · Filed Oct 6, 2025
Insider Transaction Report
Form 4
FRISSORA MARK P
Director
Transactions
- Other
Series D Convertible Preferred Stock
2025-10-01+1,517→ 51,524 totalFrom: 2026-04-01→ Common Stock (151,700 underlying)
Footnotes (2)
- [F1]Represents shares of Series D Convertible Preferred Stock issued as compensation for board services pursuant to that certain Board of Directors Agreement, dated February 3, 2025, between the Issuer and the Reporting Person.
- [F2]The Reporting Person's shares of Series D Convertible Preferred Stock, par value $0.0001 per share, are convertible into shares of common stock, par value $0.0001 per share, at a ratio of 100 shares of common stock for each share of Series D Convertible Preferred Stock, subject to a 10% beneficial ownership limitation. No shares of Series D Convertible Preferred Stock may be converted until six months after the date of issuance, except in the case of liquidation, whereupon the conversion will occur immediately. Each share of Series D Convertible Preferred Stock outstanding at the time of a meeting of stockholders or a solicitation of consent is entitled to 100 votes on matters of the Issuer, without regard to the beneficial ownership limitation. The right to convert does not expire.